Pay in 4 interest-free payments of $7.10 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Trial Structure Duration: 48 weeks of treatment Participants: 338 adults randomized 2:1:1:1:1:2:2 to placebo or retatrutide groups Doses tested: 1mg, 4mg, 8mg, 12mg (all with slow titration from 2mg starting dose) Lifestyle intervention: All participants received counseling on diet (500 kcal/day deficit) and exercise (150 min/week) Primary endpoint: Percent weight change at 24 weeks Key secondary endpoints: Weight change at 48 weeks, proportion achieving 5%, 10%, 15% loss The trial used a slow titration protocol to minimize side effects: all groups except the 1mg dose started at 2mg weekly and escalated every 4 weeks
If needed, we may request recent lab work to get a clear picture of your metabolic health before starting
At Marcos Medical, we consider ourselves lifelong learners, always working toward advancement and improvement
When diagnoses rise shortly after starting a medication, that pattern often reflects finding something that was already there, Rashmi Roy, MD, FACS, coauthor of the white paper, said
